Did France’s Regulator Follow the Law When Rejecting a Temporary Use Request for Ivermectin Targeting COVID-19?

Did France’s Regulator Follow the Law When Rejecting a Temporary Use Request for Ivermectin Targeting COVID-19

Apparently, the topic of ivermectin isn’t appreciated by drug regulators in the great nation of France. France’s National Agency for the Safety of Medicine and Health Products (ANSM) may have flouted the law in making a decision to reject ivermectin under the Recommendation for Temporary Use (RTU) in total secrecy, reports Gerard Maudrux, a French physician. He was showcased by TrialSite in March. Authoring an informative piece in FranceSoir Le miracle de l'ivermectine recently, Dr. Maudrux explored the importance of ivermectin as a potential therapy targeting SARS-CoV-2, the virus behind COVID-19. The French physician shared that ANSM completely disregarded disclosure requirements. While the 2011 “Reinforcement of Health Security of Medicinal and Health Products” law is clear in regards to the necessary transparency associated with key drug and device decision making, government representatives chose not to follow along. Outraged at this decision (and the way they went about making it), Dr. Maudrux secured the signatures of 1,500 physicians in 100 French departments in a letter protesting what the collective group deems an egregious violation of transparency principles promulgate...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee